Table 3

Comparison of demographic and clinical characteristics of patients with CLTSS.

CharacteristicsCLTSS
N = 24
Non-CLTSS
N = 26
P Value
Demographics
 Age, y61.0 (52.0, 73.0)51.5 (44.5, 60.0)0.022
 Male gender8 (33%)5 (19%)0.3
 Body mass index, kg/m226.6 (23.8, 31.4)26.3 (24.2, 29.6)0.9
Comorbidities
 Obesity7 (29%)6 (23%)0.6
 Hypertension11 (46%)3 (12%)0.007
 Depression11 (46%)3 (12%)0.007
 Anxiety9 (38%)5 (19%)0.2
 Alcoholism6 (25%)7 (27%)0.9
 Smoking5 (21%)6 (23%)0.8
 Diabetes5 (21%)2 (7.7%)0.2
 Renal failure2 (8.3%)1 (3.8%)0.6
 Hepatic failure1 (4.2%)0 (0%)0.5
 Previous surgery18 (75%)17 (65%)0.5
Clinical manifestations
 Symptom duration, mo16.0 (0.0, 120)7.1 (0.0, 58.0)0.023
 Radicular/neck pain18 (78%)21 (81%)>0.9
 Paresthesia/tingling17 (71%)18 (69%)>0.9
 Reduced muscle strength14 (58%)10 (38%)0.2
 Gait changes14 (58%)10 (38%)0.2
 Numbness/hypoesthesia8 (33%)5 (19%)0.3
 Headache5 (21%)3 (12%)0.5
 Sensory impairment4 (17%)1 (3.8%)0.2
Radiological findings
 Cervical segments, n 2.5 (2.0, 3.0) 2.0 (2.0, 3.0) 0.4
 1 0 (0%) 2 (7.7%) 0.5
 2 12 (50%) 12 (46%) 0.8
 3 8 (33%) 11 (42%) 0.5
 4 or more 4 (17%) 1 (3.8%) 0.2
 C2–C3 2 (8.3%) 0 (0%) 0.2
 C3–C4 10 (42%) 5 (19%) 0.084
 C4–C5 21 (88%) 23 (88%)  >0.9
 C5–C6 21 (88%) 25 (96%) 0.3
 C6–C7 11 (46%) 10 (38%) 0.6
 C7–T1 1 (4.2%) 0 (0%) 0.5
 Disc herniation 21 (88%) 23 (88%)  >0.9
 Foraminal stenosis 17 (74%) 16 (62%) 0.4
 Central canal stenosis 12 (50%) 7 (27%) 0.093
 Myelopathy 7 (29%) 4 (15%) 0.2
 Ligament flavum hypertrophy 5 (21%) 7 (27%) 0.6
 Spondylolisthesis 2 (8.3%) 0 (0%) 0.2
  • Abbreviation: CLTSS, cervicolumbar tandem spinal stenosis.

  • Note: Data are displayed as n (%) or median (interquartile range).

  • a Duration of symptoms is displayed as median with range. N is the total number of participants with available information. Differences between groups were analyzed with the Fisher exact test, χ2 test, or Mann-Whitney U test, as appropriate.